• Gemcitabine in Cancer Research: Protocols, Workflows & Pitfa

  2026-04-21

  Gemcitabine, a potent DNA synthesis inhibitor with anti-tumor activity, empowers cancer researchers to dissect DNA damage response and apoptosis pathways with high precision. This guide delivers actionable workflows, protocol enhancements, and troubleshooting insights for leveraging APExBIO’s Gemcitabine across advanced oncology models.

• Molecular Docking Reveals Repurposed Vitamins as SARS-CoV-2

  2026-04-21

  This study applies molecular docking and dynamics simulations to evaluate natural compounds, particularly vitamins, as potential inhibitors of SARS-CoV-2 entry and replication. The findings highlight key interactions at the viral spike RBD–ACE2 interface and at the 3CL protease active site, suggesting new directions for antiviral therapeutics research.

• Metoprolol Tartrate: Precision β1 Blockade for Translational

  2026-04-20

  This article unpacks the mechanistic selectivity of Metoprolol Tartrate as a β1-adrenergic blocking agent and provides actionable guidance for cardiovascular and hematopoietic researchers. Drawing on recent evidence, we clarify the translational importance of selective β1-adrenergic receptor inhibition, highlight APExBIO’s high-purity formulation, and bridge findings from competitive landscapes to inform best practices in cardiovascular and hematopoietic disease models.

• CHK1 Inhibition Strategies in Breast Cancer: Role of Hormone

  2026-04-20

  This study uncovers how the therapeutic efficacy of CHK1 inhibition in breast cancer is governed by estrogen and progesterone receptor status. By linking molecular mechanisms to clinical markers, it guides refinement of targeted therapies and informs future epigenetic modulation strategies.

• Ordered DNA Frameworks Enhance Enzymatic Oligonucleotide Syn

  2026-04-19

  This article reviews a recent study demonstrating how highly ordered tetrahedral DNA nanostructures improve enzymatic oligonucleotide synthesis (EOS) by increasing enzyme accessibility and reducing deletion errors. The findings provide foundational insights for advancing DNA synthesis methods, with implications for DNA data storage and nucleic acid labeling applications.

• PML Modulates HIF1AN Ubiquitination to Drive BMSC Osteogenes

  2026-04-18

  This study uncovers how promyelocytic leukemia protein (PML) enhances bone marrow mesenchymal stem cell (BMSC) osteogenic differentiation through the targeted ubiquitination and degradation of HIF1AN, activating the PI3K/AKT pathway. The findings clarify a novel regulatory axis in osteoporosis and suggest molecular targets for bone regeneration therapies.

• Influenza Hemagglutinin (HA) Peptide: Evidence, Use, and Lim

  2026-04-17

  The Influenza Hemagglutinin (HA) Peptide is a synthetic epitope tag peptide used for detection and purification of HA-tagged proteins in molecular biology. This article details its competitive binding mechanism, solubility performance, and best-practice workflow parameters. Evidence-based benchmarks and common pitfalls are discussed for research reliability.

• Neurotensin (CAS 39379-15-2): Innovations in GPCR and miRNA

  2026-04-16

  Explore how Neurotensin, a potent Neurotensin receptor 1 activator, is revolutionizing GPCR trafficking mechanism studies and miRNA regulation in gastrointestinal cells. This article uniquely bridges spectral interference insights with practical assay guidance for advanced research.

• NADH as a Functional Probe: SIRT1/HIF-1α Axis and Redox Cont

  2026-04-15

  Explore how NADH (reduced nicotinamide adenine dinucleotide) enables advanced research into the SIRT1/HIF-1α pathway, redox signaling, and mitochondrial function. This article uniquely bridges metabolic regulation with practical assay decisions for disease modeling.

• EZH2 Inhibition Modulates SASP via cGAS-STING in SCLC Cells

  2026-04-14

  This study reveals that inhibiting EZH2 reduces senescence-associated secretory phenotype (SASP) induced by the HDAC inhibitor SAHA in small cell lung cancer (SCLC) cells. The findings clarify how cytoplasmic chromatin fragments activate the cGAS-STING pathway and suggest new strategies for improving SCLC therapies.

• Hepatic Interactions of PEGylated Iron Oxide Nanoparticles D

  2026-04-13

  This study systematically dissects how PEG chain length and particle size govern the hepatic cellular uptake of iron oxide nanoparticles. By revealing unexpected roles for hepatocytes and hepatic stellate cells in nanoparticle accumulation, the findings refine nanoparticle design principles for targeted liver delivery and safety.

• In Vitro Activity of Temafloxacin Against Gram-Negative Path

  2026-04-12

  This article analyzes the pivotal findings of Hardy’s 1991 study, which compared temafloxacin with established fluoroquinolones for in vitro efficacy against Gram-negative respiratory and enteric bacteria. The study demonstrates temafloxacin’s low MICs across a spectrum of clinically relevant pathogens, supporting its role as a precision tool for antibacterial research and resistance investigations.

• JZL184: Selective Monoacylglycerol Lipase Inhibitor for CNS

  2026-04-12

  JZL184 is a potent, selective monoacylglycerol lipase inhibitor widely used to modulate endocannabinoid signaling in preclinical neuropharmacology. Its mechanism—blocking 2-AG hydrolysis—enables precise investigation of CB1-mediated synaptic modulation and associated behavioral phenotypes.

• Hexetidine (NSC-17764): Applied Workflows for Oral Biofilm A

  2026-04-11

  Hexetidine (NSC-17764) stands out as a broad-spectrum antibacterial agent for oral infections, with robust, evidence-backed performance in both planktonic and biofilm inhibition assays. This article translates bench research and clinical findings into actionable protocols, comparative insights, and troubleshooting guidance—empowering researchers to optimize outcomes in oral microbiology.

• PA-824: Workflow Advances for Bicyclic Nitroimidazole Deriva

  2026-04-11

  PA-824, a potent bicyclic nitroimidazole derivative, enables robust, reproducible Mycobacterium tuberculosis assays even under drug-resistant scenarios. This article delivers workflow enhancements, troubleshooting strategies, and actionable protocol parameters, translating recent mechanistic breakthroughs into practical laboratory gains.

16629 records 1/1109 page Next 12345 下5页 Last page